Niki BioSolutions, Inc.
NIKI
Last
$4.00
Day
-5.4%
1y
+82.3%
5y
-83.4%
52w
-64.7%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
—
EMA 21
5.05
EMA 50
5.44
EMA 200
3.57
20d high
-26.7%
5y high
-84.1%
5y range
14th
Positions held
Your positionsNIKI isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-5
Hold
avoid
Signal
Sell
Target
$4.98
Stop
$3.77
Stop distance
5.8%
Target vs last
+24.5%
Fundamentals
| Market cap | $13.47M | Enterprise value | -$4.16M | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | 0.16 | Beta | -1.00 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -17.1% | ROA | -10.0% | Debt / equity | 0.28 |
| Current ratio | 0.45 | Free cash flow | -$1.72M | Analyst recommendation | none | Mean target | — |
| 52w high | $24.00 | 52w low | $4.10 |
Quarterly
| 2025-Q4 | 2025-Q3 | |
|---|---|---|
| Revenue | $0.0M | $0.0M |
| Op margin | — | — |
| Net income | -$0.3M | -$0.6M |
| Gross margin | — | — |
| Gross profit | — | — |
| Operating income | -$0.8M | -$0.6M |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.4M | $1.3M | — |
| Op margin | — | — | -2457.5% | -1325.2% | — |
| Net income | -$1.4M | -$4.3M | -$2.8M | -$9.8M | — |
| Gross margin | — | — | 2.4% | 6.2% | — |
| Gross profit | $0.0M | $0.0M | $0.0M | $0.1M | — |
| Operating income | -$1.8M | -$3.0M | -$10.6M | -$17.2M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsNIKI · daily-10.4% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin